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June Supplement 201172S AbstractsSIR and the pick-up rate for asymptomatic SIR at three
years was 98.3% and 98.7% (p0.456), 82% and
83.5%(p0.876) and 48% (n33/68) and 45%(n25/
56)(p0.34) respectively in protocol I and II. The two
protocols initiated asymptomatic SIR in 7.5% of patients
(mean 197; 35-1543 days). Symptomatic SIRs are more
likely to occur within 30-day (mean 22; 1-1132 days)
from the deployment.
Conclusions: Our study showed that the type of sur-
veillance imaging modality did not appear to influence the
SIR rate while symptoms still trigger a significant rate of
SIR following EVAR.
Author Disclosures: E. Chisci: Nothing to disclose;G. de
Donato: Nothing to disclose; C. Setacci: Nothing to
disclose; F. Setacci: Nothing to disclose.
PS162.
Greater Saphenous Vein Assessment Using Computed
Tomographic Angiography
Kelly Kempe1, William Harkrider2, Arturo D. Gonzalez2,
Michel E. Comeaux2. 1Louisiana State University Depart-
ment of Surgery, New Orleans, LA; 2University Medical
Center, Lafayette, LA
Objectives: The greater saphenous vein (GSV) is
incidentally visualized on computed tomographic an-
giography (CTA). While the GSV is not the subject of
the CTA study, its presence, anatomy and size can be
assessed. This may assist in preoperative venous utiliza-
tion planning.
Methods: A retrospective review of 50 patients who
had a CTA with runoff of bilateral lower extremities was
performed. The machine used in the study was a VCT 64
channel. The GSV was thoroughly followed using strict
anatomical criteria in the axial views. Each vein diameter
was measured at the sapheno-femoral junction, mid thigh,
patella andmid calf. Vein size was recorded as either greater
than or less than 2mm. The vein was logged as surgically
absent if the GSV was not visualized and surgical clips were
associated with its path. Above the knee amputation legs
were excluded. Below the knee amputation legs were
included.
Results: Fifty patients and 98 legs were included in the
study. Two patients had above the knee amputations and
these legs were omitted. Of the 98 legs in our study, 8
GSV’s were surgically absent. Ninety veins were available
for characterization. Seventy-five veins (83%) were greater
than 2 mm in its entirety and 15 (17%) veins were less than
2 mm in some major portion of the vein. CTA identified
100% of the saphenous veins.
Conclusions: The data suggests that if CTA is the
arterial imaging modality, the GSV is incidentally visual-
ized and these images may be utilized in surgical plan-
ning. The GSV is visualized secondary to the tissue fat
interphase and no additional contrast, radiation or cost
($) is necessary. Further comparison studies with ultra- Cound are needed to confirm the size, continuity and
uality of the GSV.
uthor Disclosures: M. E. Comeaux: Nothing to dis-
lose; A. D. Gonzalez: Nothing to disclose; W.
arkrider: Nothing to disclose; K. Kempe: Nothing to
isclose.
S164.
Simplified Stratification System is Effective at Select-
ng Patients with a High Likelihood of Hypercoagu-
ble Disorders
oseph Naoum, Tiffany Street, Nayef Chahine, Jean Bis-
uth, Hossam El-Sayed, Heitham Hassoun, Eric Peden,
ark G. Davies, Alan B. Lumsden. The Methodist Hospi-
al, Houston, TX
Objectives: Thrombosis of vascular conduits or native
essels remains a challenging problem affecting the vascular
atient. Hypercoagulable disorders can lead to deep vein
hrombosis (DVT), arterial thrombosis or embolization,
nd early or recurrent bypass graft failure. Patients at risk for
hypercoagulable vascular event have been underestimated
nd identifying those patients can be important for their
anagement.
Methods: We reviewed clinical data on 300 consec-
tive patients. A hypercoagulable workup was performed
f patients presented with (1) early bypass /graft throm-
osis (30 days), (2) multiple bypass / graft thrombo-
es, (3) a history of DVT, Pulmonary embolus (PE) or
ative vessel thrombosis. Relevant clinical variables were
nalyzed.
Results: 85 patients (47 women; age 53  16 years,
ange 16 - 82 years) had one of the defined conditions and
nderwent a hypercoagulable evaluation. Screening was
one in 9% of patients for early bypass graft thrombosis,
0% of patients were screened because of multiple bypass or
raft thromboses, and 31% had a previous history of DVT,
E or native vessel thrombosis. 62 patients (73%) had an
bnormal hypercoagulable profile, 25 patients had only one
bnormality, 21 patients had 2, 8 patients had 3, 3 patients
ad 4, 4 patients had 5, and 1 patient had 6 abnormal
alues, respectively. An elevated homocysteine level was
resent in 38% of patients, lupus anticoagulant was present
n 34%, heparin antibodies in 22%, functional protein S
eficiency in 20%, antithrombin III deficiency in 15%,
unctional protein C deficiency in 11 %, anticardiolipin
ntibodies in 8%, and Factor V Leiden mutation in 2%,
espectively.
Conclusions: Hypercoagulable disorders are not un-
ommon in patients in a vascular surgery practice and its
ncidencemay not be well recognized. Patients who present
ith either early graft thrombosis, repeated graft thrombo-
is, and venous or native vessel thrombosis warrant a hyper-
oagulable evaluation.
uthor Disclosures: J. Bismuth: Nothing to disclose; N.
hahine: Nothing to disclose; M. G. Davies: Nothing to
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Nothing to disclose; A. B. Lumsden: Nothing to disclose;
J. Naoum: Nothing to disclose; E. Peden: Nothing to
disclose; T. Street: Nothing to disclose.
PS166.
ABO Blood Type is not Associated with Outcome after
Vascular Surgery
Koen M. van de Luijtgaarden, Erik J. Bakker, Sanne E.
Hoeks, Michiel T. Voute, Yvette R. van Gestel, Hence J.
Verhagen, Don Poldermans. Vascular Surgery, Erasmus
MC, Rotterdam, Netherlands
Objectives: Non-O blood types are associated with
higher levels of von Willebrand factor and factor VIII
and with increased risk of coronary, cerebral and periph-
eral arterial disease and venous thromboembolism. We
hypothesize that non-O blood type is a predictor of
long-term mortality after vascular surgery, although this
effect might be diminished by aspirin and/or Vitamin K
Antagonist use.
Methods: In 3255 major vascular surgery patients,
baseline characteristics, ABO blood type and follow-up
(mean 5 years) were obtained. The primary endpoint was
all-cause mortality, the secondary endpoint was Major Ad-
verse Cardiac Event (MACE). Multivariate analyses, cor-
recting for gender, medical history, left ventricular dysfunc-
tion and smoking, were used to evaluate the impact of ABO
blood type on mortality.
Results: Cardiovascular risk factors, medication and
type of surgery were well balanced between groups. All
patients were on chronic ASA/VKA therapy. Within 30 (ays after surgery, 3.4% of non-O and 3.6% of O patients
uffered MACE (OR 0.94; 95%CI 0.65-1.37). In a multi-
ariate model, O blood type was not associated with in-
reased mortality during long-term follow-up (HR 0.98;
5%CI 0.89-1.09).
Conclusions:Although associated with atherothrombo-
is and increased mortality in CAD, non-O blood type is not
ssociated with either short or long-termmortality in vascular
urgery patients. This discrepancy might be explained by the
igh rate of ASA/VKA use in our population.
uthor Disclosures: E. J. Bakker: Baxter Healthcare
orporation,Research Grants; S. E. Hoeks: Dutch foun-
ation “Lijf en Leven”,Research Grants; D. Poldermans:
erck,Research GrantsNovartis,Research GrantsMedtronic,
esearch Grants; K. M. van de Luijtgaarden: Nothing to
isclose; Y. R. van Gestel: Nothing to disclose; H. J.
erhagen: Cook, Consulting fees or other remuneration
payment)Medtronic, Consulting fees or other remunera-
ion (payment)Gore, Consulting fees or other remunera-
ion (payment); M. T. Voute: Dutch Heart Foundation,
esearch Grants.
S168.
o Ethnic Differences and TASC Distribution Affect
he Incidence of Lower Extremity Amputation?
icholas J. Gargiulo1, David J. O’Connor2, William D.
uggs1, Larry A. Scher1, Omer Riaz1, Ashish Raju1, Yana
tkin1, Evan C. Lipsitz1. 1Department of Cardiovascular and
horacic Surgery, Albert Einstein College of Medicine and
ontefiore Medical Center, New York, NY; 2Mount Sinai
chool of Medicine, New York, NY
Objectives: There has been recent interest in ethnic
ifferences with a wide variety of disease entities. This
tudy was initiated to better determine what if any factors
ffected a diverse ethnic population afflicted with CLI.
Methods: We reviewed all patients presenting with
LI from January 1, 2007 to December 31, 2007. All
atients underwent conventional arteriography and if pos-
ible an endovascular, open or hybrid procedure for suc-
essful limb salvage. Multivariate logistic regression was
hen used to determine any association between ethnic
ackground and Rutherford Class, co-morbid conditions,
ransAtlantic InterSociety Consensus II (TASC II) classi-
cation, runoff score, types of intervention (open, endovas-
ular or hybrid), prior and repeat procedures, mortality and
ne-year amputation free survival (outcome).
Results: One hundred and forty eight patients pre-
ented with primary, secondary or tertiary CLI over this
ne year period. Of these, 58 (40% ) were Black,
7 (40%) were Latino and 28 (20%) were White. There
as no difference in clinical presentation among the
hree races (P 0.02). All groups had similar rates of
ASC II D iliac disease, however Blacks had a higher
revalence of TASC II D femoropopliteal disease
P0.02). Latinos and Caucasians had a higher preva-
